Back to search

Clinical‐grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation

Data up to Jan 2025

Published2008
Citations47
References19

Total Citations Per Year

Abstract

References (19)

Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

2002 • 3,274 citations

Hematopoietic Stem-Cell Transplantation

2006 • 2,345 citations

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

2005 • 1,715 citations

Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation

1999 • 993 citations

Prospects for the use of NK cells in immunotherapy of human cancer

2007 • 525 citations

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

2004 • 254 citations

Good manufacturing practices production of natural killer cells for immunotherapy: a six‐year single‐institution experience

2007 • 114 citations

Ex vivo Expansion of Highly Purified NK Cells for Immunotherapy after Haploidentical Stem Cell Transplantation in Children

2005 • 108 citations

Use of natural killer cells in hematopoetic stem cell transplantation

2005 • 86 citations

Purification of human natural killer cells using a clinical-scale immunomagnetic method

2003 • 74 citations

Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation

2006 • 66 citations

Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children

2002 • 61 citations

Quality of Life (QoL) as Predictive Mediator Variable for Survival in Patients with Intracerebral Neoplasma During Radiotherapy

2003 • 45 citations

Genetically haploidentical stem cell transplantation for acute leukemia

2001 • 30 citations

HLA and KIR polymorphisms affect NK-cell anti-tumor activity

2007 • 30 citations

ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3− NK cells

2007 • 25 citations

Allogeneic transplantation across major HLA barriers

2001 • 24 citations

High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation

2002 • 23 citations

Leukapheresis for the extraction of monocytes and various lymphocyte subpopulations from peripheral blood: product quality and prediction of the yield using different harvest procedures

2005 • 14 citations

Cited By (0)

Loading...
Clinical‐grade purification of natural killer cells in haploidentical hematopoietic stem… (2008) – Transfusion | Metascience Observatory Explorer